ZEISS microscope developers win the Deutscher Zukunftspreis 2022

The development of the ZEISS Lattice Lightsheet 7 for the gentle 3D imaging of living cells was honored with the Federal President's Award for Technology and Innovation Jena/Berlin, Germany -- Today, the President of Germany, Frank-Walter Steinmeier, awarded the Deutscher Zukunftspreis 2022, The Federal President's Award for Technology and Innovation, to the team from ZEISS [...]

Introducing the StellarLAB- Spectroscopy Lounge and Laboratory

StellarNet announces the opening of our new StellarLAB, Spectroscopy Lounge and Laboratory. This new 2,000 sqft hi-tech space is dedicated to the science of spectroscopy and customer application development and demonstration. The laboratory has dedicated work areas for specific experimentation including Raman spectroscopy, UV-VIS and Fluorescence, NIR, SpectroRadiometry, & Colorimetry. https://www.youtube.com/watch?v=JeEvgUUJkGc Each space is outfitted [...]

PacBio Announces Onso, the Highly Accurate Short-Read Sequencing Platform

he Onso Sequencing System is Designed to Deliver Industry-Leading Sensitivity and Specificity for Novel Insights in Oncology and Disease Research MENLO PARK, Calif. -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the commencement of external beta testing of the Onso™ sequencing system. This innovative benchtop short-read DNA sequencing platform is expected to [...]

PacBio Announces Revio, a Revolutionary New Long Read Sequencing System Designed to Provide 15 Times More HiFi Data and Human Genomes at Scale for Under $1,000

Significant Advances in SMRT Cell Design, Compute, and a New System Architecture Will Enable Revio to Dramatically Increase Throughput and Lower Cost While Leveraging the Power of HiFi for Exceptional Accuracy and Direct Methylation Detection MENLO PARK, Calif. -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the Revio™ long-read sequencing system, which will enable [...]

CATALYZE DALLAS LAUNCHES ALMADEN GENOMICS, ENTERING RACE TO ADVANCE PACE OF GENOMIC RESEARCH

DALLAS -- Catalyze Dallas Holdings today announces the launch of another portfolio company, Almaden Genomics, which is accelerating genomic research and discovery through streamlined bioinformatics. Almaden is the latest in a series of commercialization efforts by Catalyze to speed go-to-market for technology harvested from the Fortune 100. "The global genomics market is expected to reach nearly $129 billion [...]

Syncell Selects $50,000 Grant Opportunity Winners for Spatial Proteomics

Researchers studying breakthrough discoveries in immunotherapy and neurological disease awarded access to Microscoop system TAIPEI, Taiwan & LOS ALTOS, Calif. -- -Syncell, pioneering innovative tools to accelerate the world’s understanding of proteomics, today announced Melissa Wren, Ph.D., & Dmytro Morderer, Ph.D., of the Dr. Wilfried Rossoll Lab at Mayo Clinic and Sofia Mensurado, Ph.D., of the Dr. Bruno [...]

EVIDENT Opens New Asia-Pacific Headquarters in Singapore

New facility supports customers and employees in the APAC region with leading-edge technology SINGAPORE -- Evident announced the opening of its new Asia-Pacific (APAC) headquarters in Singapore, marking its ongoing commitment to expand its business and operations in the APAC region. The headquarters leads Evident’s strategy, technology and innovation in the APAC region, which includes [...]

Preclinical biotherapeutics company Abalone Bio and bioinformatics cloud platform provider PipeBio announce collaborative efforts in antibody drug discovery

EMERYVILLE, Calif. and HORSENS, Denmark -- Abalone Bio, a preclinical biotherapeutics company and PipeBio, a bioinformatics cloud platform provider, announce their continued collaboration around antibody bioinformatics analysis supporting Abalone Bio's antibody discovery research and development efforts. PipeBio's advanced bioinformatic platform complements Abalone Bio's Functional Antibody Selection Technology (FAST) antibody discovery platform, which aims to find treatments [...]

PacBio Announces Revio, a Revolutionary New Long Read Sequencing System Designed to Provide 15 Times More HiFi Data and Human Genomes at Scale for Under $1,000

Significant Advances in SMRT Cell Design, Compute, and a New System Architecture Will Enable Revio to Dramatically Increase Throughput and Lower Cost While Leveraging the Power of HiFi for Exceptional Accuracy and Direct Methylation Detection MENLO PARK, Calif. -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the Revio™ long-read sequencing system, which will enable [...]

PacBio Announces Onso, the Highly Accurate Short-Read Sequencing Platform

The Onso Sequencing System is Designed to Deliver Industry-Leading Sensitivity and Specificity for Novel Insights in Oncology and Disease Research MENLO PARK, Calif. -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the commencement of external beta testing of the Onso™ sequencing system. This innovative benchtop short-read DNA sequencing platform is expected to provide [...]

Access IBO on Knowledge Center